David Bell
Directeur/Membre du Conseil chez BIOTEST AG
Fortune : 184 895 $ au 30/04/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Tomás Dagá Gelabert | M | 68 |
Grifols USA, Inc.
Grifols USA, Inc. Medical SpecialtiesHealth Technology Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA.
Biomat USA, Inc.
Biomat USA, Inc. Medical/Nursing ServicesHealth Services Biomat USA, Inc. provides plasma derived blood products. The company is headquartered in Los Angeles, CA.
BPC Plasma, Inc.
BPC Plasma, Inc. Pharmaceuticals: MajorHealth Technology BPC Plasma, Inc. manufactures pharmaceutical products. It offers the hyper immunoglobulin Nabi-HB, a key product used in the prevention of hepatitis B. The company was established in 2007 and is headquartered in Boca Raton, FL.
Alkahest, Inc.
Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | 24 ans |
Raimon Grifols Roura | M | 61 |
Grifols USA, Inc.
Grifols USA, Inc. Medical SpecialtiesHealth Technology Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA. | 23 ans |
Lafmin Morgan | M | 60 |
Grifols USA, Inc.
Grifols USA, Inc. Medical SpecialtiesHealth Technology Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA. | 14 ans |
Jun Xu | M | 60 | 12 ans | |
Víctor Grifols Roura | M | 74 |
Grifols USA, Inc.
Grifols USA, Inc. Medical SpecialtiesHealth Technology Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA. | 39 ans |
Alfredo Arroyo Guerra | M | 67 |
Grifols USA, Inc.
Grifols USA, Inc. Medical SpecialtiesHealth Technology Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA. | 17 ans |
David S. Johnson | M | - |
GigaGen, Inc.
GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | 14 ans |
Peter Janssen | M | 58 | 2 ans | |
Nuria Pascual Lapeña | F | 61 | 28 ans | |
Thomas Heinrich Glanzmann | M | 65 | 18 ans | |
Vicente Blanquer Torre | M | 64 | 37 ans | |
Zheng Liu | M | 54 | 17 ans | |
Kent Tammy | M | - |
Alkahest, Inc.
Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | - |
Ling Peng | F | 45 | 4 ans | |
Ya Min Chen | M | 72 | 2 ans | |
Albert Coma-Cros | M | - | 20 ans | |
James Costos | M | 61 | 4 ans | |
Jörg Schüttrumpf | M | 50 | 12 ans | |
Enriqueta Felip Font | M | 59 | 5 ans | |
Wei Bing Hu | M | 60 | 21 ans | |
Nacho Abia | M | 55 | - | |
Carter Keller | M | - |
GigaGen, Inc.
GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | - |
Carina Szpilka Lázaro | F | 56 | 9 ans | |
Anita Brikman | F | - |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | 1 ans |
Susana González Rodríguez | F | 47 | 2 ans | |
Karoly Nikolich | M | - |
Alkahest, Inc.
Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | 10 ans |
Elia Stupka | M | - |
Alkahest, Inc.
Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | 8 ans |
William R. Stopher | M | - |
Grifols USA, Inc.
Grifols USA, Inc. Medical SpecialtiesHealth Technology Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA. | - |
Montserrat Lloveras Calvo | F | 62 | 33 ans | |
Bing Yu Wang | M | 58 | 2 ans | |
Chuck Wilson | M | 59 |
GigaGen, Inc.
GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | - |
Íñigo Sánchez-Asiaín Mardones | M | 59 | 9 ans | |
Dirk Neumüller | M | - | 23 ans | |
Le Qi Chen | M | 37 | 3 ans | |
Oscar Calsamiglia | M | - |
GigaGen, Inc.
GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | - |
Maria Teresa Rioné Llano | F | 58 | 6 ans | |
Daniel Fleta Coit | M | 54 | 23 ans | |
Ainhoa Mendizabal Zubiaga | F | 52 | 1 ans | |
Oliver Hein | M | - | 7 ans | |
Yao Li | M | 61 | 17 ans | |
Jaume Amat | M | - |
VCN Biosciences SL
VCN Biosciences SL Miscellaneous Commercial ServicesCommercial Services Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million. | - |
Montserrat Muñoz Abellana | F | - | 2 ans | |
Fernando Sebastian Rodriguez Haro | M | 45 | 8 ans | |
Julie So-Young Kim | F | - |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | - |
Dirk Schuck | M | - | 2 ans | |
Christian Polus | M | - | - | |
Montserrat Gaja Llamas | F | 58 | 3 ans | |
Sheila Keating | F | - |
GigaGen, Inc.
GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | - |
Hong Qiu | M | - | - | |
Nick Lemoine | M | - |
VCN Biosciences SL
VCN Biosciences SL Miscellaneous Commercial ServicesCommercial Services Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million. | - |
Gabriel Capellà | M | - |
VCN Biosciences SL
VCN Biosciences SL Miscellaneous Commercial ServicesCommercial Services Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million. | - |
Saul Villeda | M | - |
Alkahest, Inc.
Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | - |
Enrico D'Aiuto | M | - | 9 ans | |
Elizabeth Jeffords | F | - |
Alkahest, Inc.
Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | - |
Stephan Fleck | M | - | 22 ans | |
Joseph E. Rosen | M | 81 |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | - |
Josefine Buth | M | - | 23 ans | |
John A. Todd | M | - |
Singulex, Inc.
Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | 17 ans |
Carl Gordon | M | 59 |
Singulex, Inc.
Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | 17 ans |
Mary J. Kuhn | F | 65 |
Grifols USA, Inc.
Grifols USA, Inc. Medical SpecialtiesHealth Technology Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA. | 13 ans |
Richard Popp | M | - |
Singulex, Inc.
Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | 14 ans |
Ramón Riera Roca | M | 70 |
Grifols USA, Inc.
Grifols USA, Inc. Medical SpecialtiesHealth Technology Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA. | 13 ans |
Rolf K. Hoffmann | M | 64 |
BPC Plasma, Inc.
BPC Plasma, Inc. Pharmaceuticals: MajorHealth Technology BPC Plasma, Inc. manufactures pharmaceutical products. It offers the hyper immunoglobulin Nabi-HB, a key product used in the prevention of hepatitis B. The company was established in 2007 and is headquartered in Boca Raton, FL. | - |
Dennis Jackman | M | - |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | - |
Heiner Dreismann | M | 69 |
Singulex, Inc.
Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | 17 ans |
H. Edward Matveld | M | - |
Grifols USA, Inc.
Grifols USA, Inc. Medical SpecialtiesHealth Technology Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA. | - |
Stephen Rose | M | 59 |
Singulex, Inc.
Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | 20 ans |
Fred K. Vogt | M | 79 |
Singulex, Inc.
Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | 22 ans |
Dirk Büscher | M | 60 |
VCN Biosciences SL
VCN Biosciences SL Miscellaneous Commercial ServicesCommercial Services Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million. | - |
Jennifer Keller | F | - |
GigaGen, Inc.
GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | 11 ans |
Yue Wen Zheng | M | 62 | 17 ans | |
Bernhard R. M. Ehmer | M | 69 | 2 ans | |
Mark Stene | M | - |
Singulex, Inc.
Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | - |
Raquel Lumbreras | F | - | - | |
Monika Buttkereit | M | - | 15 ans | |
Nuria Martín Barnés | F | 65 | 23 ans | |
Whitney Herd | M | - |
Grifols USA, Inc.
Grifols USA, Inc. Medical SpecialtiesHealth Technology Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA. | - |
Uta Kemmerich-Keil | F | 58 | 2 ans | |
Jürgen Heilmann | M | 62 | 42 ans | |
Christina Erb | M | - | 12 ans | |
José Vicente Terencio | M | 57 |
VCN Biosciences SL
VCN Biosciences SL Miscellaneous Commercial ServicesCommercial Services Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million. | - |
Giles Platford | M | - |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | - |
Tommy Trong Hoang | M | 57 | 4 ans | |
Binh Hoang | M | 50 | 17 ans | |
Hui Lu | M | 49 | 15 ans | |
Ji Hui Chen | M | 58 | 20 ans | |
Patricia Ryan | F | - |
Singulex, Inc.
Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | 10 ans |
Martin Möller | M | - | - | |
Karen Richards | F | - |
Singulex, Inc.
Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | 12 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Nancy E. Pecota | F | 64 | 10 ans | |
Igor Gonda | M | 76 | 17 ans | |
Steven Mayer | M | 65 | 12 ans | |
Victor Grifols Deu | M | 48 | 8 ans | |
Juergen Froehlich | M | 68 | 5 ans | |
Frederick Hudson | M | 78 | 5 ans | |
Tamar Howson | F | 75 | 9 ans | |
Francis H. Barker | M | 93 | 14 ans | |
Abdulaziz Al-Khayyal | M | 70 |
University of California, Irvine
| 6 ans |
Jan M. Bult | M | - |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | - |
Cui Hua Yang | M | 53 | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 44 | 44,00% |
Espagne | 30 | 30,00% |
Allemagne | 18 | 18,00% |
Chine | 16 | 16,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- David Bell
- Réseau Personnel